Comparison of Asymmetric Dimethylarginine Levels Between Stages Three, Four, and Five Non-dialysis of Chronic Kidney Disease
Aim: to determine the differences of ADMA level between stages 3, 4, and 5 non-dialysis of chronic kidney disease (CKD) patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital. Methods: a cross-sectional study was conducted on stage 3, 4, and 5 non-dialysis CKD patients at Outpatient Nephro...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Interna Publishing
2016-09-01
|
| Series: | Acta Medica Indonesiana |
| Subjects: | |
| Online Access: | https://www.actamedindones.org/index.php/ijim/article/view/134 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim: to determine the differences of ADMA level between stages 3, 4, and 5 non-dialysis of chronic kidney
disease (CKD) patients at Outpatient Nephrology Clinic, Dr. Soetomo Hospital. Methods: a cross-sectional
study was conducted on stage 3, 4, and 5 non-dialysis CKD patients at Outpatient Nephrology Clinic, Dr.
Soetomo Hospital, Surabaya from January to February 2015. Stages of CKD were determined based on GFR
estimation according to 4-variable MDRD formula. Statistical analysis of differences in the levels of ADMA in
three subject groups use one-way ANOVA test. Results:seventy-five patients were included in the study. Each
group consisted of 25 patients stage 3, 4, and, 5 non-dialysis patients. Mean age of stage 3, stage 4, and stage
5 non-dialysis CKD patients were respectively 57.12 years, 54.80 years and 53.68 years. The mean levels of
ADMA in stage 3, stage 4, and 5 were 0.62 (0.11) IU/mL, 0.72 (0.16) IU/mL, and 0.73 (0.18) IU/mL respectively.
Analysis of the differences between the groups showed significant differences in ADMA levels (p=0.04), with the
highest difference between stage 3 and stage 5. Conclusion:comparison of ADMA levels showed significant
differences between CKD stages and the level tends to be higher along with increase severity of CKD stages. |
|---|---|
| ISSN: | 0125-9326 2338-2732 |